![]() In most cases, however, the persons concerned were not in danger. In these latter cases, the people affected were either treated in hospital or their reactions were classified as medically significant for other reasons. In the cases classified as severe (n = 396) the average age was 69.3 years, and for reports temporally linked to a death (n = 55) it was 83.7 years.Īt 778 (66.3%) most of the reports were classified as not serious, while 396 reports (33.7%) were classified as serious. The average age of those affected was 64.9 years (range 16–101), with 41.7% aged 75 or over. Men were affected in 28.3% of cases, and there were a few cases (3.2%) where no gender was specified. The majority of the reports concerned women (68.6%). Retrospectively, however, there is an approximate reporting rate of one per 1,000 doses administered. Since there is often a delay in sending reports on adverse drug reactions to Swissmedic and it also takes time to carefully evaluate them, it is not possible to directly compare the reports shown here with the vaccinations given. the patients.Īccording to information from the FOPH, around 1.6 million vaccine doses have been administered in Switzerland up to and including 4 April 2021, and approximately 604,000 people have been fully vaccinated. Most of the reports were submitted by medical professionals while 92 (7.8%) came directly from those affected, i.e. ![]() A small number of reports explicitly describe reactions following the second dose of the vaccine (n=79 for Comirnaty, n=78 for Moderna). ![]() In seventeen cases, the vaccine was not specified. ![]() 577 reports involve Pfizer/BioNTech's Comirnaty®, while 580 are associated with Moderna's COVID-19 vaccine. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |